NEW YORK, Sept. 12, 2024 — The Gross Law Firm is notifying shareholders of Verve Therapeutics, Inc. (NASDAQ: VERV).
Investors who purchased VERV stock during the specified period are encouraged to contact the firm about potential lead plaintiff designation. It’s important to note that being appointed as lead plaintiff is not a requirement to receive any potential recovery.
CONTACT US HERE:
CLASS PERIOD: August 9, 2022 to April 1, 2024
ALLEGATIONS: The lawsuit alleges that during the class period, Defendants made statements that were materially false and/or misleading, and/or failed to disclose certain information. Specifically, the complaint alleges that: (1) defendants did not fully disclose the circumstances leading to the halting of the Heart-1 Phase 1b clinical trial of VERVE-101, its investigational gene editing medicine; (2) defendants overstated the potential benefits of their proprietary lipid nanoparticle delivery system; and (3) as a result, defendants’ statements about their business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
DEADLINE: October 28, 2024 Shareholders are urged to register for this class action without delay. Register your information here:
NEXT STEPS FOR SHAREHOLDERS: After registering as a shareholder who purchased VERV shares during the timeframe indicated above, you will be added to a portfolio monitoring software to receive status updates throughout the case. The deadline to seek lead plaintiff status is October 28, 2024. There is no cost or obligation associated with participating in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm. Our mission is to protect the rights of all investors who have suffered losses due to deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies operate responsibly and demonstrate good corporate citizenship. We seek recovery on behalf of investors who have incurred losses resulting from false and/or misleading statements or the omission of material information by a company, which leads to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email:
Phone: (646) 453-8903
SOURCE The Gross Law Firm